Avivomed Inc.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Biotech
- Headquarters
- Roseville, MN
- Street
- 2896 Centre Pointe Drive
- Zip
- 55113
Offering
- Total offering
- $12M
- Amount sold
- $5M
- First sale
- Apr 16, 2026
- Min investment
- $0
- Securities
- Debt
- Federal exemption
- Rule 506(b)
- Investors so far
- 7
How this filing compares
Ranked #8 of 47 Biotech filings in April 2026 by offering amount.
Median Biotech filing in April 2026: $3M. This offering is 4.0× the median.
Other Minnesota filings this week: Nascent Surgical Holdings, LLC, Rise Opportunities 15 LLC, STILLY SPIRITS LLC, AdvisorNet Financial, Inc, Outlier Fund, L.P.
Leadership
Paul Mazanec — Executive Officer (also: Director)
Mudit K. Jain — Director
Ketan Patel — Director
Also named on: Rainmaker Capital LLC
Theresa C. Pappas — Director
Casper de Clercq — Director
Also named on: Route 92 Medical, Inc.
Douglas Reed — Director
Also named on: Hatteras CREATE SF SPV, LLC
Filing details
Avivomed Inc. filed a Form D with the SEC on April 21, 2026.